These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7026199)

  • 1. Effect of indomethacin on antihypertensive action of captopril in hypertensive patients.
    Fujita T; Yamashita N; Yamashita K
    Clin Exp Hypertens (1978); 1981; 3(5):939-52. PubMed ID: 7026199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
    Abe K; Ito T; Sato M; Haruyama T; Sato K; Omata K; Hiwatari M; Sakurai Y; Imai Y; Yoshinaga K
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():141s-144s. PubMed ID: 7004721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
    Abe K; Itoh T; Imai Y; Sato M; Haruyama T; Sakurai Y; Goto T; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1980 May; 44(5):422-5. PubMed ID: 6993721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.
    Moore TJ; Crantz FR; Hollenberg NK; Koletsky RJ; Leboff MS; Swartz SL; Levine L; Podolsky S; Dluhy RG; Williams GH
    Hypertension; 1981; 3(2):168-73. PubMed ID: 6260645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition and prostaglandins.
    Swartz SL; Williams GH
    Am J Cardiol; 1982 Apr; 49(6):1405-9. PubMed ID: 6280473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system.
    Quilley J; Duchin KL; Hudes EM; McGiff JC
    J Hypertens; 1987 Feb; 5(1):121-8. PubMed ID: 3295035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin inhibits the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
    Abe K; Itoh T; Imai Y; Sato M; Goto T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1980 Sep; 132(1):117-8. PubMed ID: 7010681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endogenous angiotensin II and prostaglandins in the antihypertensive mechanism of angiotensin converting enzyme inhibitor in hypertension.
    Omata K; Abe K; Tsunoda K; Yasujima M; Chiba S; Sato M; Kudo K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):569-74. PubMed ID: 3038419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin.
    Witzgall H; Hirsch F; Scherer B; Weber PC
    Clin Sci (Lond); 1982 Jun; 62(6):611-5. PubMed ID: 7044652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
    Miyamori I; Brown MJ; Dollery CT
    Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.
    Swartz SL; Williams GH; Hollenberg NK; Levine L; Dluhy RG; Moore TJ
    J Clin Invest; 1980 Jun; 65(6):1257-64. PubMed ID: 6997332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of captopril on prostaglandin and natriuresis in patients with essential hypertension.
    Hornych A; Safar M; Simon A; Levenson J; Bariety J; Milliez P
    Am J Cardiol; 1982 Apr; 49(6):1524-6. PubMed ID: 7041590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man.
    Goldstone R; Martin K; Zipser R; Horton R
    Prostaglandins; 1981 Oct; 22(4):587-98. PubMed ID: 6275456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin does not attenuate the hypotensive effect of captopril, a converting enzyme inhibitor in Goldblatt hypertensive rats.
    Omata K; Otsuka Y; Chiba S; Itoh T; Gotoh T; Imai Y; Sakurai Y; Satoh M; Haruyama T; Hiwatari M; Satoh K; Kaitoh A; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1981 May; 134(1):9-19. PubMed ID: 7031986
    [No Abstract]   [Full Text] [Related]  

  • 16. The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():95s-99s. PubMed ID: 7004744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
    Zacharieva S; Koev D; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.